Care in this field is transforming rapidly. To optimise patient outcomes and navigate evolving treatment pathways, clinicians need a clear, evidence-based guide to the latest breakthroughs in blood disorders and malignancies.
The new edition of EMJ Hematology is now live, bringing together high-impact research, clinical insights, and exclusive coverage from EHA 2026.
Key Clinical Focus Areas
We cut through the data to bring you the research defining modern clinical practice:
- Targeted Therapies in AML: Expert strategies to optimise treatment protocols and overcome resistance in IDH1-mutated acute myeloid leukaemia.
- Next-Generation Myeloma Care: Emerging trial evidence and novel therapeutic combinations reshaping the future of multiple myeloma management.
- EHA 2026 Congress Highlights: Exclusive reflections from the EHA Lifetime Achievement awardee on pivotal discoveries driving the field forward.
- Translational Research: Practice-focused analysis bridging the gap between bench science and clinical implementation in patient care.
Peer-Reviewed Insights, Fully Open-Access
Backed by contributions from over 100 world-class experts, exclusive clinical interviews, and deep-dive article reviews, EMJ Hematology is a vital resource for specialists driving the field forward.
